Akorn (AKRX) Tops Q4 EPS by 5c

Go back to Akorn (AKRX) Tops Q4 EPS by 5c

Needham & Company Downgrades Akorn (AKRX) to Hold

February 27, 2015 6:57 AM EST

Needham & Company downgraded Akorn (NASDAQ: AKRX) from Buy to Hold.

Analyst Elliot Wilbur commented, "AKRX at last delivered its fully loaded clobetasol quarter as price inflation on this formerly obscure asset has yielded a significant inflection point in base generic EPS; a step-up... More

Akorn (AKRX) PT Lifted to $60 at Guggenheim

February 26, 2015 12:39 PM EST

Guggenheim analyst Louise Chen reiterated a Buy rating and lifted her price target on Akorn (NASDAQ: AKRX) to $60.00 (from $50.00), saying she expects earnings revision to drive the stock higher.

Chen commented, "Post 4Q14 we continue to believe AKRX is well positioned for a... More